MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 1,055 Shares of The Cigna Group (NYSE:CI)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH decreased its position in shares of The Cigna Group (NYSE:CIFree Report) by 4.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,375 shares of the health services provider’s stock after selling 1,055 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in The Cigna Group were worth $6,707,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Cornerstone Wealth Management LLC boosted its position in shares of The Cigna Group by 3.6% during the 4th quarter. Cornerstone Wealth Management LLC now owns 1,636 shares of the health services provider’s stock worth $452,000 after acquiring an additional 57 shares in the last quarter. Brighton Jones LLC lifted its stake in The Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the last quarter. Lincoln Capital Corp bought a new stake in The Cigna Group during the fourth quarter worth $380,000. Montecito Bank & Trust boosted its holdings in shares of The Cigna Group by 20.2% in the 4th quarter. Montecito Bank & Trust now owns 2,390 shares of the health services provider’s stock valued at $660,000 after purchasing an additional 401 shares in the last quarter. Finally, Goldstein Advisors LLC increased its stake in shares of The Cigna Group by 25.5% in the 4th quarter. Goldstein Advisors LLC now owns 1,083 shares of the health services provider’s stock valued at $299,000 after purchasing an additional 220 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Stock Performance

Shares of CI stock opened at $294.98 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The business’s 50 day simple moving average is $298.30 and its 200 day simple moving average is $326.03. The stock has a market capitalization of $82.05 billion, a PE ratio of 27.83, a PEG ratio of 0.78 and a beta of 0.54.

The Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. During the same period in the prior year, the firm posted $6.77 EPS. The company’s quarterly revenue was up 29.8% on a year-over-year basis. As a group, research analysts forecast that The Cigna Group will post 28.5 earnings per share for the current year.

Wall Street Analyst Weigh In

CI has been the topic of several research analyst reports. Barclays raised their price objective on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Piper Sandler reiterated an “overweight” rating and set a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Stephens reaffirmed an “overweight” rating and set a $410.00 target price on shares of The Cigna Group in a research note on Friday, November 1st. Finally, StockNews.com cut The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $395.93.

Read Our Latest Stock Report on The Cigna Group

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.